9.56
price down icon4.69%   -0.47
pre-market  Vorhandelsmarkt:  9.30   -0.26   -2.72%
loading
Schlusskurs vom Vortag:
$10.03
Offen:
$9.94
24-Stunden-Volumen:
159.35K
Relative Volume:
0.89
Marktkapitalisierung:
$348.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.88%
1M Leistung:
-4.69%
6M Leistung:
-52.93%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$9.25
$9.94
1-Wochen-Bereich:
Value
$9.15
$11.07
52-Wochen-Spanne:
Value
$7.13
$29.74

Rapport Therapeutics Inc Stock (RAPP) Company Profile

Name
Firmenname
Rapport Therapeutics Inc
Name
Telefon
857-321-8020
Name
Adresse
1325 BOYLSTON STREET, BOSTON
Name
Mitarbeiter
69
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
RAPP's Discussions on Twitter

Vergleichen Sie RAPP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RAPP
Rapport Therapeutics Inc
9.56 348.91M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-02 Eingeleitet Jefferies Buy
2024-07-02 Eingeleitet Stifel Buy
2024-07-02 Eingeleitet TD Cowen Buy

Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten

pulisher
Mar 31, 2025

Rapport Therapeutics: Too Early To Be Interesting (NASDAQ:RAPP) - Seeking Alpha

Mar 31, 2025
pulisher
Mar 31, 2025

Swiss National Bank Purchases New Stake in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 31, 2025
pulisher
Mar 27, 2025

Analyzing Neurogene (NASDAQ:NGNE) & Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

(RAPP) Long Term Investment Analysis - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 26, 2025

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 26, 2025
pulisher
Mar 23, 2025

Vanda Pharmaceuticals (NASDAQ:VNDA) and Rapport Therapeutics (NASDAQ:RAPP) Financial Contrast - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Rapport Therapeutics to present data at 2025 AAN meeting - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting - GlobeNewswire

Mar 21, 2025
pulisher
Mar 21, 2025

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting - GlobeNewswire Inc.

Mar 21, 2025
pulisher
Mar 15, 2025

Several Insiders Invested In Rapport Therapeutics Flagging Positive News - Simply Wall St

Mar 15, 2025
pulisher
Mar 15, 2025

Positive Signs As Multiple Insiders Buy Rapport Therapeutics Stock - Yahoo Canada Finance

Mar 15, 2025
pulisher
Mar 15, 2025

Insider Buying: Rapport Therapeutics Chief Financial Officer Bought US$101k Of Shares - Yahoo Finance

Mar 15, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics CFO Troy Ignelzi buys $100,988 in stock - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics director Wendy Young acquires $61,249 in stock - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics Executives Acquire Shares - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics CFO Troy Ignelzi buys $100,988 in stock By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics Reports Q4 Net Loss Of $19.98 Mln - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics reports Q4 EPS (57c) vs. ($8.01) last year - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics Inc Q4 Net Loss $20.0 Million -March 11, 2025 at 07:20 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Has $182,000 Stock Position in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

New York State Common Retirement Fund Acquires New Position in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

(RAPP) On The My Stocks Page - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 04, 2025

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development - BioSpace

Mar 04, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics appoints new chief medical officer By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics, Inc. Announces Appointment of Jeffrey Sevigny as Chief Medical Officer - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics appoints new chief medical officer - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics Announces Appointment of Dr. Jeffrey - GlobeNewswire

Mar 03, 2025
pulisher
Feb 24, 2025

Rapport Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Feb 24, 2025
pulisher
Feb 22, 2025

Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - Defense World

Feb 22, 2025
pulisher
Feb 20, 2025

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 8.5%Here's What Happened - MarketBeat

Feb 20, 2025
pulisher
Feb 13, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap UpHere's Why - MarketBeat

Feb 13, 2025
pulisher
Feb 12, 2025

How To Trade (RAPP) - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 11, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 5.6%What's Next? - MarketBeat

Feb 11, 2025
pulisher
Feb 10, 2025

Jennison Associates LLC Acquires Shares of 62,287 Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Feb 10, 2025
pulisher
Feb 05, 2025

Rapport Therapeutics (NASDAQ:RAPP) Short Interest Down 15.3% in January - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

JPMorgan Chase & Co. Purchases Shares of 4,033 Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

Rapport Therapeutics (NASDAQ:RAPP) Trading Up 4.6%Here's What Happened - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

J&J-backed Rapport Therapeutics files for $100M IPO - MSN

Feb 02, 2025
pulisher
Feb 01, 2025

Rapport Therapeutics (RAPP) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

(RAPP) Proactive Strategies - Stock Traders Daily

Jan 31, 2025
pulisher
Jan 31, 2025

Rapport Therapeutics (RAPP) Projected to Post Quarterly Earnings on Thursday - Defense World

Jan 31, 2025

Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)

Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
Kapitalisierung:     |  Volumen (24h):